Skip to main content
. Author manuscript; available in PMC: 2015 Nov 1.
Published in final edited form as: Drug Alcohol Depend. 2014 Sep 22;144:193–200. doi: 10.1016/j.drugalcdep.2014.09.007

Table 3.

Sensitivity analysis for estimated avoided costs when compared to the referent health state of relapse (2013 CAD).

Health
state
Monthly avoided costs [95% C.I.]

(1) Baseline (2) Third party (3) Arrests & charges (4) Balanced panel
Full sample (2232 observations)
Health state:
  Relapse Referent health state
  Opioid abstinence $6563** [$1564, $11,561] $5859*** [$1539, $10,178] $312** [$6, $618] $6531*** [$1729, $11,333]
  MMT high effectiveness $6298*** [$1578, $11,017] $5551*** [$1449, $9654] $386*** [$178, $595] $6061** [$1296, $10,826]
  MMT low effectiveness $3566 [−$1118, $8250] $3223 [−$902, $7347] $19 [−$242, $280] $2975 [−$2125, $8075]

  Incident-based costs Yes Yes No Yes
  Criminal justice system costs Yes Yes Yes Yes
  Arrest costs only No No Yes No
  Victimization costs Yes No No Yes
*

p-Value <0.10

**

p-value <0.05

***

p-value <0.01.

All costs estimated from average marginal effects derived from a two-part multiple regression model.

Refers to estimates presented in Table 2.